Abstract:Breast cancer is one of the most common types of cancer in female patients with high morbidity and mortality. Multi-drug chemotherapy has significant advantages in the treatment of malignant tumors, especially in reducing drug toxicity, increasing drug sensitivity and reducing drug resistance. The objective of this research is to fabricate lipid nanoemulsions (LNs) for the co-delivery of PTX and docosahexaenoic acid (DHA) with folic acid (FA) decorating (PTX/DHA-FA-LNs), and investigate the anti-tumor activity of the PTX/DHA-FA-LNs against breast cancer both in vitro and in vivo. PTX/DHA-FA-LNs showed a steady release of PTX and DHA from the drug delivery system (DDS) without any burst effect. Furthermore, the PTX/DHA-FA-LNs exhibited a dose-dependent cytotoxicity and a higher rate of apoptosis as compared with the other groups in MCF-7 cells. The cellular uptake study revealed that this LNs were more readily uptaken by MCF-7 cells and M2 macrophages in vitro. Additionally, the targeted effect of PTX/DHA-FA-LNs was aided by FA receptor-mediated endocytosis, and its cytotoxicity was proportional to the cellular uptake efficiency. The anti-tumor efficiency results showed that PTX/DHA-FA-LNs significant inhibited tumor volume growth, prolonged survival time, and reduced toxicity when compared with the other groups. These results indicated that DHA increases the sensitivity of tumor cells and tumor-associated macrophages (ATM2) to PTX, and synergistic effects of folate modification in breast cancer treatment, thus PTX/DHA-FA-LNs may be a promising nanocarrier for breast cancer treatment.

Effects Of Exercise On Antitumor Efficacy Of Dhaq-Loaded Pla-Pll-Rgd Nanoparticles In Hepatocellular Carcinoma

Preparation of DHAQ-loaded PLA-PLL-RGD Nanoparticles and Comparison of Antitumor Efficacy to Hepatoma and Breast Carcinoma

[Effect of Physical Exercise on the Efficacy of Mitoxantrone-Loaded Nanoparticles in Treating Early Breast Cancer].

Antitumor Efficacy of Paclitaxel-Loaded Polylactide/ Poly(ethylene Glycol) Nanoparticles Combination with Exercise in Tumor-Bearing Mice.

Study on the Anticarcinogenic Effect and Acute Toxicity of Liver-Targeting Mitoxantrone Nanoparticles

Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy

Pronounced Enhancement in Radiosensitization of Esophagus Cancer Cultivated in Docosahexaenoic Acid via the PPAR - γ Activation

DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma.

The Targeting Mechanism of Dha Ligand and Its Conjugate with Gemcitabine for the Enhanced Tumor Therapy

Enhancing Therapeutic Effects of Docetaxel-Loaded Dendritic Copolymer Nanoparticles by Co-Treatment with Autophagy Inhibitor on Breast Cancer

Antitumor Effects of Polydopamine Coated Hydroxyapatite Nanoparticles and Its Mechanism: Mitochondria-targeted ROS and Calcium Channels

Dihydroartemisinin Exhibits Antitumor Activity Toward Hepatocellular Carcinoma in Vitro and in Vivo.

Polyglutamic Acid-Coordinated Assembly of Hydroxyapatite Nanoparticles for Synergistic Tumor-Specific Therapy.

Anti-tumor Effect of DHA on Ovarian Cancer and its Mechanism

Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis In Liver Cancer In Vitro And In Vivo

Doxorubicin-loaded Glycyrrhetinic Acid-Modified Alginate Nanoparticles for Liver Tumor Chemotherapy.

The Effect of Autophagy Inhibitors on Drug Delivery Using Biodegradable Polymer Nanoparticles in Cancer Treatment.

Biodegradable Iron-Coordinated Hollow Polydopamine Nanospheres For Dihydroartemisinin Delivery And Selectively Enhanced Therapy In Tumor Cells

Enhanced in Vivo Antitumor Efficacy of Dual-Functional Peptide-Modified Docetaxel Nanoparticles Through Tumor Targeting and Hsp90 Inhibition.

A nano-preparation approach to enable the delivery of daphnoretin to potentiate the therapeutical efficacy in hepatocellular cancer

Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro